MSC2017-WebsiteStaticBanner

November 24-25, 2017 Events Center, Festival City, Dubai, UAE

Granted 14.0 CME hours (Category 1) by the Dubai Health Authorities (DHA).

WELCOME NOTE

DOWNLOAD THE FLYER

Dear Colleagues,

It gives me great pleasure to invite you to participate in the Third Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS) Congress which will take place from November 24th to 25th, 2017 in Dubai.

 

The congress aim is to provide a forum of excellence in MS education and research. Building on the collective efforts of the scientific committee, the meeting will deliver state-of-the-art presentations on MS by renowned international and regional keynote speakers. The content of the meeting includes up to date information on the latest treatments, clinical research, therapeutic strategies, pathology, imaging, epidemiology, diagnosis, biomarkers, neuromyelitis optica, and much more.

 

The congress will convene over a two-day period to present major updates through plenary sessions and scientific symposia. This year’s congress will also feature parallel sessions addressed to nurses in collaboration with the International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centers (CMSC), and to regional MS societies in collaboration with the MS International Federation (MSIF). In addition, the European Charcot Foundation will participate in the meeting through a scientific symposium.

 

The congress is also a great opportunity to meet and network with colleagues interested in the field of MS clinical care. More than 600 healthcare professionals from the MENA region are expected to attend. We look forward to welcoming participants from all over the world to the lively cosmopolitan city Dubai.

Sincerely,

Prof. Bassem I. Yamout
President
MENACTRIMS

MSC2017-STD

DOWNLOAD THE PROGRAM

PROGRAM

IN COLLABORATION WITH


TARGET AUDIENCE

  • Healthcare professionals and researchers involved in MS clinical care or research.
  • Neurologists
  • Clinical Researchers
  • Residents with interest in Neurology

ACCREDITATION

The Third MENACTRIMS Congress is granted 14.0 CME Hours (category 1) by the Dubai Health Authority (DHA).



CONGRESS HIGHLIGHTS

Tracks on:

  • Recent advances in MS therapy
  • MS pathology
  • Immunology of MS
  • Epidemiology of MS
  • MS diagnosis
  • Update on Secondary Progressive MS
  • Neuromyelitis Optica
  • Pediatric MS
  • Biomarkers in MS


CONGRESS OVERVIEW

Tracks on:

  • Plenary sessions covering all major topics in MS
  • Full day parallel session in collaboration with the IOMSN-CMSC aimed at MENA region nurses
  • Full day parallel session in collaboration with the MSIF aimed at MENA region MS organizations
  • European Charcot Foundation Symposium

VENUE